ArticleACS measurement science au2026
Highly Sensitive and Robust Detection of Human Telomerase Based on Strand-Displacement Cascade Amplification.
Article in ACS measurement science au, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Telomerase is a well-validated diagnostic target for the early screening of cancers. To address the limitations of existing sensing methods, we herein fabricate a novel strategy based on the delicate integration of strand displacement cascade amplification and three-dimensional DNA nanostructure-assisted signal immobilization. Modified magnetic nanocomposites and electrodes provide suitable reaction interfaces, which facilitate a convenient purification process. The fabricated electrochemical method not only exhibits good sensitivity, selectivity, and stability but also demonstrates great utility for telomerase inhibitor screening and tumor cell discrimination. Besides, validation with human urine samples confirms the concordance with the clinical diagnostic conclusion. Therefore, this method holds significant potential as a point-of-care testing tool for telomerase-related applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.